Point your AI agent at freehire and let it find you a job.

Get the CLI →

Corcept Therapeutics

Develops pharmaceutical treatments that regulate cortisol hormone activity.

H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
Discussion
biotechhealthcaremental-healthpharmaceuticals

Company facts

Founded
1998
Employees
730
Headquarters
United States
CEO
Robert J. Lutz
Type
Public
Listed
NASDAQ: CORT
Subsidiaries
Corcept Endocrinology

About

Corcept Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative drugs to treat serious disorders related to cortisol, a hormone that plays a pivotal role in the body’s stress response. Our mission is to improve the lives of patients who suffer from conditions associated with excessive cortisol, including Cushing's syndrome and major depressive disorder. Founded in 1998, our team of experienced professionals is committed to advancing our proprietary technology and delivering effective therapeutics to those in need. We leverage our expertise in cortisol modulation to design treatments that improve patient outcomes and enhance quality of life.

46 jobs

Tailor your CV for this role?

We couldn't check your fit for this role — add a CV to your profile to see it next time.

A new version of freehire is available